AtriCure, Inc

About Us

As a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. Our Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. Our AtriClip Left Atrial Appendage Exclusion System products are the most widely used LAA management devices worldwide. Our Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients, and our cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. We invest in innovation, clinical science, and education to focus on improving lives for our patients worldwide.

Mission
We are passionately focused on reducing the global Afib epidemic and healing the lives of those affected.

Values
We work to heal the lives of Patients, empower our People, and collaborate with our Partners to reduce the burden of Afib worldwide.

Career Opportunities Available In:

Clinical & Regulatory Affairs
Research and Development
Professional Education
Operations/Manufacturing
Compliance
Quality Assurance
Sales
Administration
Finance
Information Technology
Human Resources
Marketing
Customer Service

Served over 450,000 patients with ablation worldwide
Over 3,000 healthcare professionals trained
Products sold in approximately 60 countries
Over 380,000 AtriClip devices sold worldwide
More than 1,000 employees worldwide
Headquartered near Cincinnati, Ohio